JOURNAL ARTICLES

Song Y, Seo I, Tian C, An J, Park S, Hyun J, Jung S, Park HJ, Bhang SH♱, Cho SY♱. Unveiling aging heterogeneities in human dermal fibroblasts via nanosensor chemical cytometry. Submitted

Park HM*, Kim CL*, Kong D, Heo SH♱, Park HJ♱. Innovations in vascular repair from mechanical intervention to regenerative therapies. Submitted

Bheri S, Hoffman JR, Park HJ, Gaul D, Moore S, ME Davis. Membrane composition of cardiac-derived extracellular vesicles changes with vesicle origin and determines uptake. Submitted

Kim YJ, Kim H, Lee DH, Kim YH, Park JH, Sim WS, Kim JJ, Ban K, Um SH, Park HJ, ME Davis, Park HJ, Bhang SH. Feasibility assessment of 3D printing-based tubular tissue flap in a porcine model for long segmental tracheal reconstruction. Submitted 

Park JH, Brown NE, Tucker SJ, Temenoff JS, El-Deiry M, Park HJ, Tkaczuk AT, Hollister SJ. Feasibility assessment of 3D printing-based tubular tissue flap in a porcine model for long segmental tracheal reconstruction. In revision

Takaesu F, Yasseen K, Yang E, Park HJ, Kelly JM, Breuer CK, Davis ME. Transcriptomic analysis of circulating extracellular vesicles during the perioperative period of Fontan and Glenn surgery. In revision 

Pham HTM, Kim HS, Nguyen DL, Joo HW, Kim MK, Sung YK, Vu MH, Hahm HS, Kim WJ, Kim JH♱, Park HJ♱. High-throughput screening of 3D co-culture hair follicle mimetic tissue with enhanced ECM matrix for the screening of hair growth promoting compounds. In revision

Bheri S, Park HJ, Hoffman JR, Takaesu F, Davis ME. The Effect of Parent Cell Type on Small Extracellular Vesicle-Derived Vehicle Functionality. Adv Biol 2024, 8(3): 2300462 (2023 IF: 3.2) 

Hoffman JR, Park HJ, Bheri S, Platt MO, Hare JM, Kaushal S, Bettencourt JL, Lai D, Slesnick TC, Mahle WT, Davis ME. Statistical modeling of extracellular vesicle cargo to predict clinical trial outcomes for hypoplastic left heart syndrome. iScience 2023, 26(10): 107980 (2022 IF: 5.8) 

Pham HTM*, Nguyen DL*, Kim HS, Yang EK, Kim JH♱, Yoon HC♱, Park HJ♱. A novel and cost-effective method for high-throughput 3D culturing and rhythmic assessment of hiPSC-derived cardiomyocytes using retroreflective Janus microparticles. Biomater Res 2023, 27:79 (2022 IF: 11.3) 

Bheri S, Brown ME, Park HJ, Brazhkina O, Takaesu F, Davis ME. 3D Customized loading of microRNA-126 to small extracellular vesicle-derived vehicles improves cardiac function after myocardial infarction. ACS Nano 2023, 17(20): 19613-19624 (2022 IF: 17.1) 

Park JH*, Park HJ*, Tucker SJ, Rutledge SR, Wang L, Davis ME, Hollister SJ. 3D Printing of Poly-ε-caprolactone (PCL) Auxetic Implant with Advanced Performance for Large Volume Soft Tissue Engineering. Adv Funct Mater 2023, 33(24):2215220 (2022 IF: 19) 

Kim J*, Kim J*, Park HJ*, Jeon EJ, Cho SW. A microfluidic platform for simulating stem cell migration using in vivo-like gradients of stem cell mobilizer. Korean J Chem Eng 2023, 40(4):903-909 (2022 IF: 2.7)

Park HJ, Hoffman JR, Brown ME, Bheri S, Brazhkina O, Son YH, Davis ME. Knockdown of deleterious miRNA in progenitor cell-derived small extracellular vesicles enhances tissue repair in myocardial infarction. Sci Adv 2023, 9(9): eab04616 (2022 IF: 13.8) 

Park HJ*, Kelly JM*, Hoffman JR, Takaesu F, Schwartzman W, Ulziibayar A, Kitsuka T, Heuer E, Yimit A, Malbrue R, Anderson C, Morrison A, Naguib A, Mckee C, Andrew H, Boe B, Armstrong A, Salavitabar A, Yates A, Shinoka T, Carrillo S, Davis ME. Computational analysis of serum-derived extracellular vesicle miRNAs in juvenile sheep model of single stage Fontan procedure. Extracell Vesicle 2022, 1: 100013 

Hoffman JR, Park HJ, Bheri S, Arun JR, Davis ME. Comparative computational RNA analysis of cardiac-derived progenitor cells and their extracellular vesicles. Genomics 2022, 114(3): 110349 (2021 IF: 5.736) 

Streeter BW, Brown M, Shakya P, Park HJ, Qiu J, Xia Y, Davis ME. Using computational methods to design patient-specific electrospun cardiac patches for pediatric heart failure. Biomaterials 2022, 283: 121421 (2021 IF: 15.304) 

Bejleri D, Robeson MJ, Brown ME, Hunter J, Maxwell JT, Streeter BW, Brazhkina O, Park HJ, Christman KL, Davis ME. In vivo evaluation of bioprinted cardiac patches composed of cardiac-specific extracellular matrix and progenitor cells in a model of pediatric heart failure. Biomater Sci 2021, 10:444-456 (2020 IF: 6.843) 

Brazhkina O*, Park JH*, Park HJ, Hollister SC, Davis ME. 3D printed auxetic patch for enhanced electric signaling between human pluripotent stem cell-derived cardiomyocytes. J Cardiovasc Dev Dis 2021, 8(12): 172. (2020 IF: 3.948)     * co-first authors 

Bheri S, Hoffman JR, Park HJ, Davis ME. Engineering cardiac small extracellular-derived vehicles with thin-film hydration for customized microRNA loading. J Cardiovasc Dev Dis 2021, 8(11): 135. (2020 IF: 3.948) 

Park HJ, De Jesus Morales KJ, Bheri S, Davis ME. Bidirectional relationship between cardiac cellular matrix and cardiac cells in ischemic heart disease. Stem Cells 2021, 39(12): 1650-1659. (2020 IF: 6.277) 

Bheri S, Hoffman JR, Park HJ, Davis ME. Biomimetic Nanovesicle Design for Cardiac Tissue Repair. Nanomedicine 2020;15(19). (2020 IF: 5.307) 

Yoon JK*, Kim DH*, Kang ML*, Jang HK, Park HJ, Lee JB, Yi SW, Kim HS, Baek S, Park DB, You J, Lee SD, Sei YJ, Ahn SI, Shin YM, Kim CS, Bae S, Kim Y, Sung HJ. Anti-atherogenic effect of stem cell nanovesicles targeting disturbed flow sites. Small 2020, 16(16): 2000012. (2020 IF: 13.281)      *co-first authors 

Baek J*, Cho Y*, Park HJ*, Choi G, Lee JS, Lee M, Yu S, Cho SW, Lee E, Im SG. A surface‐tailoring method for rapid non‐thermosensitive cell‐sheet engineering via functional polymer coatings. Adv Mater 2020, 32(16): 1907225. (2020 IF: 30.849)    * co-first authors 

Ahn SI, Sei YJ, Park HJ, Kim J, Ryu Y, Choi JM, Jang YC, Sung HJ, MacDonald T, Levey A, Kim Y. Microengineered human blood-brain barrier platform for understanding nanoparticle transport mechanism. Nat Commun 2020, 11: 175. (2020 IF: 14.919) 

Park HJ*, Kim S*, Jeon EJ, Song IT, Lee H, Son Y, Hong HS, Cho SW. PEGylated substance P augments therapeutic angiogenesis in diabetic critical limb ischemia. J Ind Eng Chem 2019, 78(25): 396-409. (2019 IF: 5.278)

Kang B*, Shin J*, Park HJ, Rhyou C, Kang D, Cho SW, Lee H. High-resolution acoustophoretic 3D cell patterning to construct functional collateral cylindroids for ischemia therapy. Nat Commun 2018, 9: 5402. (2018 IF:11.878) 

Anh SI*, Park HJ*, Yom J, Kim T, Kim Y. High-density lipoprotein-mimetic nanotherapeutics for cardiovascular and neurovascular disease. Nano Research 2018, 1-14. (2018 IF:8.515)

Park HJ*, Kuai R*, Jeon EJ, Seo Y, Jung Y, Moon J, Schwendeman A, Cho SW. High-density lipoprotein-mimicking nanodiscs carrying peptide for enhanced therapeutic angiogenesis in diabetic hindlimb ischemia. Biomaterials 2018, 161: 69-80. (2018 IF: 10.708)

Lee JS, Jin Y, Park HJ, Yang K, Lee MS, Yang HS, Cho SW. In situ bone tissue engineering with an endogenous stem cell mobilizer and osteoinductive nanofibrous polymeric scaffold. Biotech J 2017, 12(12):1700062. (2017 IF: 3.606) 

Kim J, Yang K, Lee JS, Hwang YH, Park HJ, Park. KI, Lee DY, Cho SW. Enhanced self-renewal and accelerated differentiation of human fetal neural stem cells using graphene oxide nanoparticles. Macromol Biosci 2017, 17(8):1600540. (2017 IF: 3.465) 

Shin J, Cho JH, Jin Y, Yang K, Lee JS, Park HJ, Han HS, Lee J, Jeon H, Shin H, Cho SW. Mussel adhesion-inspired reverse transfection platform presenting small interfering RNA-lipidoid nanoparticles to enhance osteogenic differentiation and bone formation of human adipose-derived stem cells. Small 2016, 12(45):6266-6278. (2016 IF: 8.640) 

Park HJ, Jeon EJ, Lee JS, Hong SH, Cho A-N, Lee J, Moon JS, Jung K-E, Oh JW, Lee H, Cho SW. Galactosylated lipidoid nanoparticles for delivery of small interfering RNA to inhibit hepatitis C viral replication in vivo. Adv Healthc Mater 2016, 5(22):2931-2941. (2016 IF: 5.662) 

Jin Y*, Seo J*, Lee JS, Shin S, Park HJ, Min S, Cheong E, Lee T, Cho S-W. Triboelectric nanogenerator accelerates highly efficient nonviral direct conversion and in vivo reprogramming of fibroblasts to functional neuronal cells. Adv Mater 2016, 28(34):7365-7374. (2016 IF: 20.155) 

Jin Y*, Lee JS*, Min S, Park HJ, Kang TJ, Cho SW. Bioengineered extracellular membranous nanovesicles for Efficient small-interfering RNA delivery: versatile platforms for stem cell engineering and in vivo delivery. Adv Funct Mater 2016, 26(32):5804-5817. (2016 IF: 12.541) 

Park HJ*, Jin Y*, Shin J*, Yang K, Lee C, Yang HS, Cho SW. Catechol-functionalized hyaluronic acid hydrogels enhance angiogenesis and osteogenesis of human adipose-derived stem cells in critical tissue defects. Biomacromolecules 2016, 17(6):1939-1948. (2016 IF: 5.246) 

Kim J*, Song SH*, Jin Y, Park HJ, Yoon H, Jeon S, Cho S-W. Multiphoton luminescent graphene quantum dots for in vivo tracking of human adipose-derived stem cells. Nanoscale 2016, 8:8512-8519. (2016 IF: 7.367) 

Moon JS*, Lee SH*, Han SH, Kim EJ, Lee W, Kim MK, Kim TE, Park HJ, Rhee JK, Kim SJ, Cho S-W, Han SH, Oh JW. Inhibition of hepatitis C virus in mouse models by lipidoid nanoparticle-mediated systemic delivery of siRNA against PRK2. Nanomed-Nanotechnol Biol Med 2016, 12(16):1489-1498. (2016 IF: 5.720) 

Moon JS*, Lee SH*, Kim EJ, Cho H, Lee W, Kim GW, Park HJ, Cho SW, Lee C, Oh JW. Inhibition of hepatitis C virus in mice by a small interfering RNA targeting a highly conserved sequence in viral IRES pseudoknot. PLoS One 2016, 11(1):e0146710. (2016 IF: 2.806) 

Yoon JH, Korkmaz N, Park HJ, Han S, Hwang KH, Shin J, Cho SW, Nam CH, Chung S. Angiogenic type I collagen extracellular matrix integrated with recombinant bacteriophages displaying vascular endothelial growth factors. Adv Healthc Mater 2016, 5(2):205-212. (2016 IF: 5.760) 

Yang K, Park HJ, Han S, Lee J, Ko E, Kim J, Lee JS, Y JH, Song KY, Cheong E, Cho SR, Chung S, Cho SW. Recapitulation of in vivo-like paracrine signals of human mesenchymal stem cells for functional neuronal differentiation of human neural stem cells in a 3D microfluidic system. Biomaterials 2015, 63:177-188. (2015 IF: 9.562) 

Chang J, Jung HJ, Park HJ, Cho SW, Lee SK, Kwon HJ. Cell-permeable mitochondrial ubiquinol–cytochrome c reductase binding protein induces angiogenesis in vitro and in vivo. Cancer Lett 2015, 366(1):52-60. (2015 IF: 6.791) 

Shin J*, Lee JS*, Lee C*, Park HJ, Yang K, Jin Y, Ryu JH, Hong KS, Moon SH, Chung HM, Yang HS, Um SH, Oh JW, Kim DI, Lee H, Cho SW. Tissue adhesive catechol-modified hyaluronic acid hydrogel for effective, minimally-invasive cell therapy. Adv Funct Mater 2015, 25(25):3814-3824. (2015 IF: 12.365) 

Park HJ*, Yang K*, Kim MJ, Jang J, Lee M, Kim DW, Lee H, Cho SW. Bio-inspired oligovitronectin-grafted surface for enhanced self-renewal and long-term maintenance of human pluripotent stem cells under feeder-free conditions. Biomaterials 2015, 50:127-139. (2015 IF: 9.562) 

Park HJ*, Yoo SJ*, Yang K, Jin Y, Cho AN, Kim J, Lee B, Yang HS, Im SG, Cho SW. Paper-based bioactive scaffolds for stem cell-mediated bone tissue engineering. Biomaterials 2014, 35(37):9811-9823. (2014 IF: 9.542) 

Kim J, Yang K, Park HJ, Han S, Shin Y, Lee JH, Chung S, Cho SW. Implantable microfluidic device for the formation of three-dimensional vasculature by human endothelial progenitor cells. Biotechnol Bioprocess Eng 2014, 19(3):379-385. (2014 IF: 1.282) 

Shin Y*, Yang K*, Han S, Park HJ, Cho SW, Chung S. Reconstituting vascular micro-environment of neural stem cell niche in three-dimensional extracellular matrix. Adv Healthc Mater 2014, 3(9):1457-1464. (2014 IF: 5.970) 

Lee J*, Jun I*, Park HJ, Kang TJ, Shin H, Cho SW. Genetically engineered myoblast sheet for therapeutic angiogenesis. Biomacromolecules 2014, 15(1):361-372. (2014 IF: 6.182) 

Park HJ*, Shin J*, Kim J, Cho SW. Nonviral delivery for reprogramming to pluripotency and differentiation. Arch Pharm Res 2014, 37(1):107-119. (2014 IF: 2.467) 

Park HJ*, Lee J*, Kim MJ, Kang TJ, Jeong Y, Um SH, Cho SW. Sonic hedgehog intradermal gene therapy using a biodegradable poly(beta-amino esters) nanoparticle to enhance wound healing. Biomaterials 2012, 33(35):9148-9156. (2012 IF: 8.693) 

Cho SW, Yang F, Son SM, Park HJ, Green JJ, Bogatyrev S, Mei Y, Park S, Langer R, Anderson DG. Therapeutic angiogenesis using genetically engineered human endothelial cells. J Control Release 2012, 160(3):515-524. (2012 IF: 6.238) 

Park HJ, Yang F, Cho SW, Nonviral delivery of genetic medicine for therapeutic angiogenesis, Adv Drug Deliv Rev 2012, 64(1):40-52. (2012 IF: 12.888)